These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14696464)

  • 21. Surgery of icteric-type hepatoma after biliary drainage and transcatheter arterial embolization.
    Tada K; Kubota K; Sano K; Noie T; Kosuge T; Takayama T; Makuuchi M
    Hepatogastroenterology; 1999; 46(26):843-8. PubMed ID: 10370624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult hepatocellular carcinoma: a case report of a special icteric-type hepatoma and literature review.
    Chang H; Xu J; Mu Q; Qin C; Zhang Z; Wu T
    Eur J Cancer Care (Engl); 2010 Sep; 19(5):690-3. PubMed ID: 19659667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.
    Fukuda S; Itamoto T; Nakahara H; Kohashi T; Ohdan H; Hino H; Ochi M; Tashiro H; Asahara T
    Hepatogastroenterology; 2005; 52(64):1163-7. PubMed ID: 16001653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Percutaneous laser ablation in the treatment of portal vein tumor thrombus in 93 hepatocellular carcinoma patients].
    Lu ZH; Shen F; Yuan GX; Shi LH; Zong M; Yang JH; Guo J; Wu MC
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):449-52. PubMed ID: 17974281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma].
    Fan J; Tang ZY; Wu ZQ; Zhou J; Zhou XD; Ma ZC; Qin LX; Qiu SJ; Yu Y; Huang C
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):433-5. PubMed ID: 15854367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.
    Ariizumi S; Takasaki K; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S
    Hepatogastroenterology; 2004; 51(56):500-4. PubMed ID: 15086191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.
    Ikai I; Hatano E; Hasegawa S; Fujii H; Taura K; Uyama N; Shimahara Y
    J Am Coll Surg; 2006 Mar; 202(3):431-8. PubMed ID: 16500247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.
    Lee JW; Han JK; Kim TK; Choi BI; Park SH; Ko YH; Yoon CJ; Yeon KM
    Cardiovasc Intervent Radiol; 2002; 25(3):176-9. PubMed ID: 12058212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
    Kaczynski J; Hansson G; Wallerstedt S
    Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus.
    Sakata H; Konishi M; Ryu M; Kinoshita T; Satake M; Moriyama N; Ochiai T
    Hepatogastroenterology; 2004; 51(60):1575-80. PubMed ID: 15532781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatocellular carcinoma with intraductal tumor thrombus diagnosed by ultrasonography; report of two resected cases].
    Komatsu R; Shima Y; Takahashi H; Shimamura Y; Watanabe E; Shimizu H
    Rinsho Hoshasen; 1989 Aug; 34(8):941-4. PubMed ID: 2555600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma confined to Couinaud segment VIII: experience with extensive or limited resection.
    Lin CW; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Hepatogastroenterology; 2005; 52(63):908-12. PubMed ID: 15966230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].
    Zhou J; Fan J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):3005-8. PubMed ID: 17288818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
    Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast metastasis from hepatocellular carcinoma.
    Lo HC; Lee KF; Yeh CN; Chen MF
    Hepatogastroenterology; 2004; 51(56):387-90. PubMed ID: 15086166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.